Axillary reverse mapping (ARM) in clinically node positive breast cancer patients.
Identifieur interne : 001058 ( PubMed/Checkpoint ); précédent : 001057; suivant : 001059Axillary reverse mapping (ARM) in clinically node positive breast cancer patients.
Auteurs : M A Beek [Pays-Bas] ; P D Gobardhan [Pays-Bas] ; E G Klompenhouwer [Pays-Bas] ; H J T. Rutten [Pays-Bas] ; A C Voogd [Pays-Bas] ; E J T. Luiten [Pays-Bas]Source :
- European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology [ 1532-2157 ] ; 2015.
Descripteurs français
- KwdFr :
- Adulte, Adulte d'âge moyen, Agents colorants, Aisselle, Carcinomes (), Carcinomes (anatomopathologie), Femelle, Humains, Lymphadénectomie (), Lymphoedème (), Membre supérieur, Noeuds lymphatiques (anatomopathologie), Sujet âgé, Traitement médicamenteux adjuvant, Traitement néoadjuvant, Tumeurs du sein (), Tumeurs du sein (anatomopathologie), Vaisseaux lymphatiques, Études prospectives.
- MESH :
- anatomopathologie : Carcinomes, Noeuds lymphatiques, Tumeurs du sein.
- Adulte, Adulte d'âge moyen, Agents colorants, Aisselle, Carcinomes, Femelle, Humains, Lymphadénectomie, Lymphoedème, Membre supérieur, Sujet âgé, Traitement médicamenteux adjuvant, Traitement néoadjuvant, Tumeurs du sein, Vaisseaux lymphatiques, Études prospectives.
English descriptors
- KwdEn :
- Adult, Aged, Axilla, Breast Neoplasms (pathology), Breast Neoplasms (surgery), Carcinoma (pathology), Carcinoma (surgery), Chemotherapy, Adjuvant, Coloring Agents, Female, Humans, Lymph Node Excision (methods), Lymph Nodes (pathology), Lymphatic Vessels, Lymphedema (prevention & control), Middle Aged, Neoadjuvant Therapy, Prospective Studies, Upper Extremity.
- MESH :
- chemical : Coloring Agents.
- methods : Lymph Node Excision.
- pathology : Breast Neoplasms, Carcinoma, Lymph Nodes.
- prevention & control : Lymphedema.
- surgery : Breast Neoplasms, Carcinoma.
- Adult, Aged, Axilla, Chemotherapy, Adjuvant, Female, Humans, Lymphatic Vessels, Middle Aged, Neoadjuvant Therapy, Prospective Studies, Upper Extremity.
Abstract
Axillary reverse mapping (ARM) is a technique to map and preserve upper extremity lymphatic drainage during axillary lymph node dissection (ALND) in breast cancer patients. We prospectively evaluated the metastatic involvement of ARM-nodes in patients who underwent an ALND for clinically node positive disease following (neo)adjuvant chemotherapy (NAC) in comparison to patients in whom primary ALND was performed without NAC.
DOI: 10.1016/j.ejso.2014.09.012
PubMed: 25468747
Affiliations:
Links toward previous steps (curation, corpus...)
Links to Exploration step
pubmed:25468747Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Axillary reverse mapping (ARM) in clinically node positive breast cancer patients.</title><author><name sortKey="Beek, M A" sort="Beek, M A" uniqKey="Beek M" first="M A" last="Beek">M A Beek</name><affiliation wicri:level="1"><nlm:affiliation>Department of Surgery, Amphia Hospital, Molengracht 21, 4818 CK Breda, The Netherlands. Electronic address: maarten_beek@hotmail.com.</nlm:affiliation><country xml:lang="fr">Pays-Bas</country><wicri:regionArea>Department of Surgery, Amphia Hospital, Molengracht 21, 4818 CK Breda</wicri:regionArea><wicri:noRegion>4818 CK Breda</wicri:noRegion></affiliation></author><author><name sortKey="Gobardhan, P D" sort="Gobardhan, P D" uniqKey="Gobardhan P" first="P D" last="Gobardhan">P D Gobardhan</name><affiliation wicri:level="1"><nlm:affiliation>Department of Surgery, Amphia Hospital, Molengracht 21, 4818 CK Breda, The Netherlands.</nlm:affiliation><country xml:lang="fr">Pays-Bas</country><wicri:regionArea>Department of Surgery, Amphia Hospital, Molengracht 21, 4818 CK Breda</wicri:regionArea><wicri:noRegion>4818 CK Breda</wicri:noRegion></affiliation></author><author><name sortKey="Klompenhouwer, E G" sort="Klompenhouwer, E G" uniqKey="Klompenhouwer E" first="E G" last="Klompenhouwer">E G Klompenhouwer</name><affiliation wicri:level="1"><nlm:affiliation>Department of Radiology, Catharina Hospital, Eindhoven, The Netherlands.</nlm:affiliation><country xml:lang="fr">Pays-Bas</country><wicri:regionArea>Department of Radiology, Catharina Hospital, Eindhoven</wicri:regionArea><wicri:noRegion>Eindhoven</wicri:noRegion></affiliation></author><author><name sortKey="Rutten, H J T" sort="Rutten, H J T" uniqKey="Rutten H" first="H J T" last="Rutten">H J T. Rutten</name><affiliation wicri:level="1"><nlm:affiliation>Department of Surgery, Catharina Hospital, Eindhoven, The Netherlands; Department of Surgery, Maastricht University, Maastricht, The Netherlands.</nlm:affiliation><country xml:lang="fr">Pays-Bas</country><wicri:regionArea>Department of Surgery, Catharina Hospital, Eindhoven, The Netherlands; Department of Surgery, Maastricht University, Maastricht</wicri:regionArea><wicri:noRegion>Maastricht</wicri:noRegion></affiliation></author><author><name sortKey="Voogd, A C" sort="Voogd, A C" uniqKey="Voogd A" first="A C" last="Voogd">A C Voogd</name><affiliation wicri:level="1"><nlm:affiliation>Department of Epidemiology, Faculty of Health Medicine and Life Sciences, Research Institute Growth and Development (GROW), Maastricht University, Maastricht, The Netherlands; Eindhoven Cancer Registry, Comprehensive Cancer Center South, Eindhoven, The Netherlands.</nlm:affiliation><country xml:lang="fr">Pays-Bas</country><wicri:regionArea>Department of Epidemiology, Faculty of Health Medicine and Life Sciences, Research Institute Growth and Development (GROW), Maastricht University, Maastricht, The Netherlands; Eindhoven Cancer Registry, Comprehensive Cancer Center South, Eindhoven</wicri:regionArea><wicri:noRegion>Eindhoven</wicri:noRegion></affiliation></author><author><name sortKey="Luiten, E J T" sort="Luiten, E J T" uniqKey="Luiten E" first="E J T" last="Luiten">E J T. Luiten</name><affiliation wicri:level="1"><nlm:affiliation>Department of Surgery, Amphia Hospital, Molengracht 21, 4818 CK Breda, The Netherlands.</nlm:affiliation><country xml:lang="fr">Pays-Bas</country><wicri:regionArea>Department of Surgery, Amphia Hospital, Molengracht 21, 4818 CK Breda</wicri:regionArea><wicri:noRegion>4818 CK Breda</wicri:noRegion></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2015">2015</date><idno type="RBID">pubmed:25468747</idno><idno type="pmid">25468747</idno><idno type="doi">10.1016/j.ejso.2014.09.012</idno><idno type="wicri:Area/PubMed/Corpus">001162</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">001162</idno><idno type="wicri:Area/PubMed/Curation">001162</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">001162</idno><idno type="wicri:Area/PubMed/Checkpoint">001162</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">001162</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Axillary reverse mapping (ARM) in clinically node positive breast cancer patients.</title><author><name sortKey="Beek, M A" sort="Beek, M A" uniqKey="Beek M" first="M A" last="Beek">M A Beek</name><affiliation wicri:level="1"><nlm:affiliation>Department of Surgery, Amphia Hospital, Molengracht 21, 4818 CK Breda, The Netherlands. Electronic address: maarten_beek@hotmail.com.</nlm:affiliation><country xml:lang="fr">Pays-Bas</country><wicri:regionArea>Department of Surgery, Amphia Hospital, Molengracht 21, 4818 CK Breda</wicri:regionArea><wicri:noRegion>4818 CK Breda</wicri:noRegion></affiliation></author><author><name sortKey="Gobardhan, P D" sort="Gobardhan, P D" uniqKey="Gobardhan P" first="P D" last="Gobardhan">P D Gobardhan</name><affiliation wicri:level="1"><nlm:affiliation>Department of Surgery, Amphia Hospital, Molengracht 21, 4818 CK Breda, The Netherlands.</nlm:affiliation><country xml:lang="fr">Pays-Bas</country><wicri:regionArea>Department of Surgery, Amphia Hospital, Molengracht 21, 4818 CK Breda</wicri:regionArea><wicri:noRegion>4818 CK Breda</wicri:noRegion></affiliation></author><author><name sortKey="Klompenhouwer, E G" sort="Klompenhouwer, E G" uniqKey="Klompenhouwer E" first="E G" last="Klompenhouwer">E G Klompenhouwer</name><affiliation wicri:level="1"><nlm:affiliation>Department of Radiology, Catharina Hospital, Eindhoven, The Netherlands.</nlm:affiliation><country xml:lang="fr">Pays-Bas</country><wicri:regionArea>Department of Radiology, Catharina Hospital, Eindhoven</wicri:regionArea><wicri:noRegion>Eindhoven</wicri:noRegion></affiliation></author><author><name sortKey="Rutten, H J T" sort="Rutten, H J T" uniqKey="Rutten H" first="H J T" last="Rutten">H J T. Rutten</name><affiliation wicri:level="1"><nlm:affiliation>Department of Surgery, Catharina Hospital, Eindhoven, The Netherlands; Department of Surgery, Maastricht University, Maastricht, The Netherlands.</nlm:affiliation><country xml:lang="fr">Pays-Bas</country><wicri:regionArea>Department of Surgery, Catharina Hospital, Eindhoven, The Netherlands; Department of Surgery, Maastricht University, Maastricht</wicri:regionArea><wicri:noRegion>Maastricht</wicri:noRegion></affiliation></author><author><name sortKey="Voogd, A C" sort="Voogd, A C" uniqKey="Voogd A" first="A C" last="Voogd">A C Voogd</name><affiliation wicri:level="1"><nlm:affiliation>Department of Epidemiology, Faculty of Health Medicine and Life Sciences, Research Institute Growth and Development (GROW), Maastricht University, Maastricht, The Netherlands; Eindhoven Cancer Registry, Comprehensive Cancer Center South, Eindhoven, The Netherlands.</nlm:affiliation><country xml:lang="fr">Pays-Bas</country><wicri:regionArea>Department of Epidemiology, Faculty of Health Medicine and Life Sciences, Research Institute Growth and Development (GROW), Maastricht University, Maastricht, The Netherlands; Eindhoven Cancer Registry, Comprehensive Cancer Center South, Eindhoven</wicri:regionArea><wicri:noRegion>Eindhoven</wicri:noRegion></affiliation></author><author><name sortKey="Luiten, E J T" sort="Luiten, E J T" uniqKey="Luiten E" first="E J T" last="Luiten">E J T. Luiten</name><affiliation wicri:level="1"><nlm:affiliation>Department of Surgery, Amphia Hospital, Molengracht 21, 4818 CK Breda, The Netherlands.</nlm:affiliation><country xml:lang="fr">Pays-Bas</country><wicri:regionArea>Department of Surgery, Amphia Hospital, Molengracht 21, 4818 CK Breda</wicri:regionArea><wicri:noRegion>4818 CK Breda</wicri:noRegion></affiliation></author></analytic><series><title level="j">European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology</title><idno type="eISSN">1532-2157</idno><imprint><date when="2015" type="published">2015</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adult</term><term>Aged</term><term>Axilla</term><term>Breast Neoplasms (pathology)</term><term>Breast Neoplasms (surgery)</term><term>Carcinoma (pathology)</term><term>Carcinoma (surgery)</term><term>Chemotherapy, Adjuvant</term><term>Coloring Agents</term><term>Female</term><term>Humans</term><term>Lymph Node Excision (methods)</term><term>Lymph Nodes (pathology)</term><term>Lymphatic Vessels</term><term>Lymphedema (prevention & control)</term><term>Middle Aged</term><term>Neoadjuvant Therapy</term><term>Prospective Studies</term><term>Upper Extremity</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Adulte</term><term>Adulte d'âge moyen</term><term>Agents colorants</term><term>Aisselle</term><term>Carcinomes ()</term><term>Carcinomes (anatomopathologie)</term><term>Femelle</term><term>Humains</term><term>Lymphadénectomie ()</term><term>Lymphoedème ()</term><term>Membre supérieur</term><term>Noeuds lymphatiques (anatomopathologie)</term><term>Sujet âgé</term><term>Traitement médicamenteux adjuvant</term><term>Traitement néoadjuvant</term><term>Tumeurs du sein ()</term><term>Tumeurs du sein (anatomopathologie)</term><term>Vaisseaux lymphatiques</term><term>Études prospectives</term></keywords><keywords scheme="MESH" type="chemical" xml:lang="en"><term>Coloring Agents</term></keywords><keywords scheme="MESH" qualifier="anatomopathologie" xml:lang="fr"><term>Carcinomes</term><term>Noeuds lymphatiques</term><term>Tumeurs du sein</term></keywords><keywords scheme="MESH" qualifier="methods" xml:lang="en"><term>Lymph Node Excision</term></keywords><keywords scheme="MESH" qualifier="pathology" xml:lang="en"><term>Breast Neoplasms</term><term>Carcinoma</term><term>Lymph Nodes</term></keywords><keywords scheme="MESH" qualifier="prevention & control" xml:lang="en"><term>Lymphedema</term></keywords><keywords scheme="MESH" qualifier="surgery" xml:lang="en"><term>Breast Neoplasms</term><term>Carcinoma</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Adult</term><term>Aged</term><term>Axilla</term><term>Chemotherapy, Adjuvant</term><term>Female</term><term>Humans</term><term>Lymphatic Vessels</term><term>Middle Aged</term><term>Neoadjuvant Therapy</term><term>Prospective Studies</term><term>Upper Extremity</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Adulte</term><term>Adulte d'âge moyen</term><term>Agents colorants</term><term>Aisselle</term><term>Carcinomes</term><term>Femelle</term><term>Humains</term><term>Lymphadénectomie</term><term>Lymphoedème</term><term>Membre supérieur</term><term>Sujet âgé</term><term>Traitement médicamenteux adjuvant</term><term>Traitement néoadjuvant</term><term>Tumeurs du sein</term><term>Vaisseaux lymphatiques</term><term>Études prospectives</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Axillary reverse mapping (ARM) is a technique to map and preserve upper extremity lymphatic drainage during axillary lymph node dissection (ALND) in breast cancer patients. We prospectively evaluated the metastatic involvement of ARM-nodes in patients who underwent an ALND for clinically node positive disease following (neo)adjuvant chemotherapy (NAC) in comparison to patients in whom primary ALND was performed without NAC.</div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">25468747</PMID><DateCreated><Year>2015</Year><Month>01</Month><Day>16</Day></DateCreated><DateCompleted><Year>2015</Year><Month>03</Month><Day>18</Day></DateCompleted><DateRevised><Year>2015</Year><Month>11</Month><Day>19</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1532-2157</ISSN><JournalIssue CitedMedium="Internet"><Volume>41</Volume><Issue>1</Issue><PubDate><Year>2015</Year><Month>Jan</Month></PubDate></JournalIssue><Title>European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology</Title><ISOAbbreviation>Eur J Surg Oncol</ISOAbbreviation></Journal><ArticleTitle>Axillary reverse mapping (ARM) in clinically node positive breast cancer patients.</ArticleTitle><Pagination><MedlinePgn>59-63</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.ejso.2014.09.012</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0748-7983(14)01189-5</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Axillary reverse mapping (ARM) is a technique to map and preserve upper extremity lymphatic drainage during axillary lymph node dissection (ALND) in breast cancer patients. We prospectively evaluated the metastatic involvement of ARM-nodes in patients who underwent an ALND for clinically node positive disease following (neo)adjuvant chemotherapy (NAC) in comparison to patients in whom primary ALND was performed without NAC.</AbstractText><AbstractText Label="PATIENTS AND METHODS" NlmCategory="METHODS">Patients with clinically node positive invasive breast cancer, confirmed by fine needle aspiration cytology and scheduled for primary ALND were enrolled in the study. Patients were separated into two groups: one group treated with NAC (NAC+ group) and one group not treated with NAC (NAC- group). ARM was performed in all patients by injecting blue dye into the ipsilateral upper extremity. During ALND, ARM-nodes were first identified and removed separately, followed by a standard ALND.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">91 patients were included in the NAC+ and 21 patients in the NAC- group. There was no difference in the ARM visualization rate between the two groups (86.8% for NAC+ group versus 90.5% for NAC- group, P = 0.647). In the NAC+ group 16.5% of the patients had metastatic involvement of the ARM-nodes versus 36.8% of the patients in the NAC- group (P = 0.048).</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">The risk of metastatic involvement of ARM-nodes in clinically node positive breast cancer patients is significantly lower in patients who have received NAC.</AbstractText><CopyrightInformation>Copyright © 2014 Elsevier Ltd. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Beek</LastName><ForeName>M A</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>Department of Surgery, Amphia Hospital, Molengracht 21, 4818 CK Breda, The Netherlands. Electronic address: maarten_beek@hotmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gobardhan</LastName><ForeName>P D</ForeName><Initials>PD</Initials><AffiliationInfo><Affiliation>Department of Surgery, Amphia Hospital, Molengracht 21, 4818 CK Breda, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Klompenhouwer</LastName><ForeName>E G</ForeName><Initials>EG</Initials><AffiliationInfo><Affiliation>Department of Radiology, Catharina Hospital, Eindhoven, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rutten</LastName><ForeName>H J T</ForeName><Initials>HJ</Initials><AffiliationInfo><Affiliation>Department of Surgery, Catharina Hospital, Eindhoven, The Netherlands; Department of Surgery, Maastricht University, Maastricht, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Voogd</LastName><ForeName>A C</ForeName><Initials>AC</Initials><AffiliationInfo><Affiliation>Department of Epidemiology, Faculty of Health Medicine and Life Sciences, Research Institute Growth and Development (GROW), Maastricht University, Maastricht, The Netherlands; Eindhoven Cancer Registry, Comprehensive Cancer Center South, Eindhoven, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Luiten</LastName><ForeName>E J T</ForeName><Initials>EJ</Initials><AffiliationInfo><Affiliation>Department of Surgery, Amphia Hospital, Molengracht 21, 4818 CK Breda, The Netherlands.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2014</Year><Month>10</Month><Day>29</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Eur J Surg Oncol</MedlineTA><NlmUniqueID>8504356</NlmUniqueID><ISSNLinking>0748-7983</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D004396">Coloring Agents</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001365" MajorTopicYN="N">Axilla</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001943" MajorTopicYN="N">Breast Neoplasms</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002277" MajorTopicYN="N">Carcinoma</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017024" MajorTopicYN="N">Chemotherapy, Adjuvant</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004396" MajorTopicYN="Y">Coloring Agents</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008197" MajorTopicYN="N">Lymph Node Excision</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008198" MajorTopicYN="N">Lymph Nodes</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D042601" MajorTopicYN="Y">Lymphatic Vessels</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008209" MajorTopicYN="N">Lymphedema</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention & control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020360" MajorTopicYN="N">Neoadjuvant Therapy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D034941" MajorTopicYN="N">Upper Extremity</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Axillary reverse mapping</Keyword><Keyword MajorTopicYN="N">Breast cancer</Keyword><Keyword MajorTopicYN="N">Lymphedema</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2014</Year><Month>05</Month><Day>06</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2014</Year><Month>07</Month><Day>07</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2014</Year><Month>09</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2014</Year><Month>12</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2014</Year><Month>12</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2015</Year><Month>3</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">25468747</ArticleId><ArticleId IdType="pii">S0748-7983(14)01189-5</ArticleId><ArticleId IdType="doi">10.1016/j.ejso.2014.09.012</ArticleId></ArticleIdList></PubmedData></pubmed><affiliations><list><country><li>Pays-Bas</li></country></list><tree><country name="Pays-Bas"><noRegion><name sortKey="Beek, M A" sort="Beek, M A" uniqKey="Beek M" first="M A" last="Beek">M A Beek</name></noRegion><name sortKey="Gobardhan, P D" sort="Gobardhan, P D" uniqKey="Gobardhan P" first="P D" last="Gobardhan">P D Gobardhan</name><name sortKey="Klompenhouwer, E G" sort="Klompenhouwer, E G" uniqKey="Klompenhouwer E" first="E G" last="Klompenhouwer">E G Klompenhouwer</name><name sortKey="Luiten, E J T" sort="Luiten, E J T" uniqKey="Luiten E" first="E J T" last="Luiten">E J T. Luiten</name><name sortKey="Rutten, H J T" sort="Rutten, H J T" uniqKey="Rutten H" first="H J T" last="Rutten">H J T. Rutten</name><name sortKey="Voogd, A C" sort="Voogd, A C" uniqKey="Voogd A" first="A C" last="Voogd">A C Voogd</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/PubMed/Checkpoint
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001058 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd -nk 001058 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= LymphedemaV1
|flux= PubMed
|étape= Checkpoint
|type= RBID
|clé= pubmed:25468747
|texte= Axillary reverse mapping (ARM) in clinically node positive breast cancer patients.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/RBID.i -Sk "pubmed:25468747" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd \
| NlmPubMed2Wicri -a LymphedemaV1
| This area was generated with Dilib version V0.6.31. |  |